04/17/2024
3:15 PM | Assembly Biosciences (Filer)
| Form DEFA14A | |
04/02/2024
3:25 PM | Assembly Biosciences (Issuer)
McHutchison John G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:15 PM | Assembly Biosciences (Issuer)
White Nicole S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
3:10 PM | Assembly Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
3:10 PM | Assembly Biosciences (Issuer)
Cook Robert Donald II (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/19/2024
10:01 AM | Assembly Biosciences (Issuer)
Schornstein Alexander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
3:12 PM | Assembly Biosciences (Subject)
Schornstein Alexander (Filed by)
| Form SC 13D/A | |
|
11/21/2023
3:05 PM | Assembly Biosciences (Issuer)
White Nicole S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2023
3:15 PM | Assembly Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2023
11:38 AM | Assembly Biosciences (Issuer)
Schornstein Alexander (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/25/2023
6:15 PM | Assembly Biosciences (Issuer)
GILEAD SCIENCES, INC. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/25/2023
4:18 PM | Assembly Biosciences (Subject)
GILEAD SCIENCES, INC. (Filed by)
| Form SC 13D | |
10/17/2023
6:10 AM | Assembly Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2023
3:15 PM | Assembly Biosciences (Issuer)
White Nicole S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
6:18 PM | Assembly Biosciences (Subject)
Okazaki Jason A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2023
6:20 PM | Assembly Biosciences (Subject)
Delaney William E IV (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2023
5:34 PM | Assembly Biosciences (Issuer)
White Nicole S (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/02/2023
5:01 PM | Assembly Biosciences (Subject)
Delaney William E IV (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/02/2023
5:04 PM | Assembly Biosciences (Subject)
Okazaki Jason A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/23/2023
6:03 PM | Assembly Biosciences (Issuer)
Okazaki Jason A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
6:04 PM | Assembly Biosciences (Issuer)
Delaney William E IV (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2023
4:48 PM | Assembly Biosciences (Subject)
Delaney William E IV (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/30/2023
3:40 PM | Assembly Biosciences (Issuer)
RINGO WILLIAM R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2023
3:30 PM | Assembly Biosciences (Issuer)
Mahony Susan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2023
3:30 PM | Assembly Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2023
3:35 PM | Assembly Biosciences (Issuer)
McHutchison John G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2023
3:15 PM | Assembly Biosciences (Issuer)
Consylman Gina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2023
3:20 PM | Assembly Biosciences (Issuer)
Houghton Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
4:05 PM | Assembly Biosciences (Issuer)
Delaney William E IV (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
4:10 PM | Assembly Biosciences (Issuer)
Bjorkquist Jeanette M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
4:15 PM | Assembly Biosciences (Issuer)
McHutchison John G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2023
5:30 PM | Assembly Biosciences (Subject)
McHutchison John G (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/23/2023
5:33 PM | Assembly Biosciences (Subject)
Okazaki Jason A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/23/2023
5:35 PM | Assembly Biosciences (Subject)
Delaney William E IV (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/04/2023
3:31 PM | Assembly Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
